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Abstract 
Objective Dairy food intake has been associated with 
prostate cancer in previous work, but the mechanism by 
which this occurs is unknown. Dairy calcium may suppress 
circulating levels of potentially cancer-protective 1,25-hy­
droxyvitamin D (1,25(OH)2D). We examined the associa­
tions of dairy, milk, calcium, and vitamin D intake with 
plasma 1,25(OH)2D levels among 296 men (194 black, 102 
non-black) enrolled in a high risk program for prostate 
cancer from 10/96 to 10/07. 
Methods All participants completed diet and health his­
tory questionnaires and provided plasma samples, which 
were assessed for levels of 25-hydroxyvitamin D and 
1,25(OH)2D. We used multivariate linear regression to 
examine associations with 1,25(OH)2D. 
Results After adjustment for age, race, energy intake, 
BMI, and alcohol intake, we observed no associations for 
any of our variables of interest with 1,25(OH)2D, or any 
meaningful differences in estimates by race or vitamin D 
status. 
Conclusion Our ﬁndings, in a sample including a large 
proportion of black participants, do not conﬁrm previous 
ﬁndings showing an inverse association between calcium 
intake and 1,25(OH)2D levels. As such, they suggest that 
future work should explore other mechanisms by which 
dairy foods and calcium might increase prostate cancer risk. 
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Introduction 
Although epidemiologic studies have fairly consistently 
found an increase in prostate cancer risk with intake of dairy 
foods [1], mechanisms by which dairy foods increase risk of 
prostate cancer are unknown. The hypothesis that 1,25-di­
hydroxyvitamin D (1,25(OH)2D) might protect against 
prostate cancer [2] suggests one possible mechanism: con­
sumed at sufﬁciently high levels, calcium in dairy suppresses 
production and circulating levels of 1,25(OH)2D, thereby 
increasing risk for prostate cancer [3]. Vitamin D, which is 
derived primarily from the sunlight-catalyzed synthesis of 7­
dehydrocholesterol in the skin, is converted through 
hydroxylation ﬁrst to 25-hydroxyvitamin D (25(OH)D), 
considered the better indicator for vitamin D status [4], then 
again by the enzyme 25-hydroxyvitamin D-1alpha-hydrox­
ylase (1alpha-OHase) to its biologically active form, 
1,25(OH)2D [4]. The effect of dairy intake on 1,25(OH)2D 
levels may differ by vitamin D status. Whereas a high level of 
dairy calcium may increase risk among those with adequate 
vitamin D status, in vitamin D deﬁcient men dairy foods may 
increase levels of 25(OH)D, the precursor substrate for 
Adequate vitamin D statusFig. 1 Hypothesized 
associations among dairy food, 
calcium, and vitamin D intake, 
and levels of 25­
hydroxyvitamin D (25(OH)D) 
and 1,25-dihydroxyvitamin D 
(1,25(OH)2D) 
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conversion to 1,25(OH)2D in the prostate [4], consequently, 
increasing availability of 1,25(OH)2D (Fig. 1). 
Conﬁrming associations within these pathways would 
have important implications for dairy food and calcium 
intake in prostate cancer prevention. These implications are 
particularly relevant to men at high risk for prostate cancer, 
for whom preventive measures are limited but are most 
needed. The objectives of this analysis were to evaluate the 
hypothesis that dairy food and calcium intake reduce cir­
culating 1,25(OH)2D levels in a sample of men at high risk 
for prostate cancer, including a large proportion of black 
participants. We also hypothesized that the association of 
dairy food intake with 1,25(OH)2D levels would differ by 
vitamin D status. 
Materials and methods 
Study sample 
Participants for the proposed study were men enrolled in 
the Fox Chase Cancer Center (FCCC) Prostate Cancer Risk 
Assessment Program (PRAP). PRAP was established by 
FCCC investigators in 1996 to offer education and pre­
ventive interventions to men at potentially high risk for 
prostate cancer and to serve as a research base for studying 
gene–environment interactions in prostate cancer [5]. 
PRAP participants are healthy men at high genetic risk for 
prostate cancer. Men are eligible for the program if they are 
between 35 and 69 years of age [1], and have no history of 
prostate cancer [2]. In addition, non-black men are required 
to have at least one-ﬁrst-degree relative or two same-side 
second-degree relatives with prostate cancer; no family 
history of prostate cancer is required for African American 
men because of their already elevated risk. Recruitment 
strategies include referrals from prostate cancer patients at 
FCCC, radio and newspaper advertisements, and physician 
and self-referrals. 
Of 702 men enrolled in PRAP between October, 1996 
and October, 2007, we excluded those who were recruited 
through satellite locations and whose plasma samples thus 
could not be processed immediately after collection 
↑ vitamin D intake ↑ 25-D ↑ 1,25-D 
Low vitamin D status 
(n = 152); who did not provide a blood sample after July, 
2000, when standard procedures were established for pro­
cessing and storing plasma samples in the FCCC Bios-
ample Repository (n = 116); who did not return a dietary 
questionnaire (n = 108); who reported an infeasible energy 
intake (\500 or [4,400 kcal/day) (n = 18); or who had a 
previous diagnosis of cancer (n = 12), leaving 296 men 
available for these analyses. 
The project was approved by the Institutional Review 
Board at the Fox Chase Cancer Center. 
Data collection 
Upon enrollment into PRAP, men completed a health 
history questionnaire and the Harvard Diet Assessment 
Form (DAF) [6]. At initial and follow-up appointments, 
participants also contributed 51 mL of non-fasting blood 
samples for storage in the FCCC Biosample Repository. 
The health history questionnaire elicited information on 
sociodemographic characteristics, occupation, family his­
tory of prostate cancer, smoking status, physical activity, 
and self-reported height and weight. Occupational sun 
exposure was assessed based on each participant’s current 
occupation, which was classiﬁed into one of three cate­
gories according to presumed sunlight exposure (indoor 
work, combined indoor and outdoor work, outdoor work), 
using an index that was related to mortality from non-
melanoma skin cancer in previous studies [7–9]. The DAF 
elicited information on frequency of intake of 126 food 
items, and on length of use and dosage of dietary supple­
ments, including calcium. Intake of speciﬁc nutrients such 
as energy, total fat, and calcium was estimated by multi­
plying reported frequency of intake of each food by the 
nutrient content for the speciﬁed portion size. 
Assessment of plasma 25(OH)D and 1,25(OH)2D levels 
Levels of plasma 25(OH)D and 1,25(OH)2D were deter­
mined by Heartland Assays, Inc. (Ames, IA). Levels of 
25(OH)D were determined with a direct, competitive 
chemiluminescence immunoassay (CLIA) using the 
DiaSorin LIAISON platform. Levels of 1,25(OH)2D were 
determined using a competitive RIA procedure following 
extraction and subsequent puriﬁcation of vitamin D 
metabolites from the plasma samples using C18OH 
cartridges. 
Statistical analyses 
We used linear regression models adjusting for age and 
race (black or non-black) to examine associations of soci­
odemographic, lifestyle, and dietary factors with 
1,25(OH)2D levels. Intake of dairy was calculated as the 
total frequency of intake of nine items in the DAF: skim or 
low fat milk, whole milk, cream, sour cream, ice cream, 
yogurt, cottage or ricotta cheese; cream cheese, and other 
cheese. Nutrient values, estimated from dietary and sup­
plemental sources, were log-transformed as necessary and 
energy-adjusted using the residual method [10]. Dietary 
variables were modeled both as continuous variables and as 
categorical variables with the lowest category as the ref­
erent group. Categorical covariates were coded using 
dummy variables to allow for non-linear associations 
across categories. 
Variables were included as potential confounders in 
multivariate models if they were signiﬁcantly associated 
with 1,25(OH)2D levels in models including all men. Final 
multivariate models included 288 men with complete 
covariate data and adjusted for age (years), race (black, 
non-black), energy intake (kcal), BMI (kg/m2), and alcohol 
intake (0,[0 to\6.5,[6.5 to\26, C26 g/day). Models for 
dietary variables also adjusted for energy intake (kcal), and 
models for calcium and vitamin D intake were mutually 
adjusted for the other variable. Additional analyses with 
25(OH)D as the outcome also adjusted for season of blood 
draw because of its strong association with 25(OH)D lev­
els. Other variables evaluated as confounders but not 
included in ﬁnal models were level of education, family 
history of prostate cancer, physical activity, total fat intake, 
and occupational sun exposure. 
To evaluate the possibility that associations differ by 
vitamin D status, we compared estimates derived from 
models stratiﬁed on 25(OH)D level. We deﬁned low 
25(OH)D levels using a cut point of B15 ng/mL 
(37.5 nmol/L), which deﬁnes the lower limit of the normal 
range of 25(OH)D levels [11] and has been used as a cri­
terion to deﬁne low vitamin D status in other studies [12, 
13]. We estimated p-values for interaction from models 
including all men, with dairy or calcium intake 9 vitamin 
D status (25(OH)D level B 15 or [15 ng/mL) interaction 
terms. Dairy and calcium variables were analyzed as both 
continuous and categorical variables. We conducted similar 
analyses to examine potential effect modiﬁcation by race 
(black, non-black). Because results stratiﬁed on race were 
not meaningfully different, we present results for all men 
or in subsets deﬁned only based on 25(OH)D levels. 
Results 
Distributions of relevant variables and their associations 
with 1,25(OH)2D level are shown in Table 1. The majority 
of our sample (66%) were black, and about half of the 
sample (47%) were classiﬁed as having low 25(OH)D 
levels. Black participants were more likely to have low 
vitamin D levels than were non-black participants (61% vs. 
20%). Further, of 139 men with 25(OH)D level B 15 ng/mL, 
119 (86%) were black, vs. 75 (48%) of 157 men with 
25(OH)D level [ 15 ng/mL. In age- and race-adjusted lin­
ear regression analyses, only 25(OH)D level was a signiﬁ­
cant predictor of 1,25(OH)2D level, although associations 
for BMI, vitamin D intake, and alcohol intake were 
marginally signiﬁcant (Table 1). A surprisingly inverse 
association of outdoor occupation with 1,25(OH)2D level 
was non-signiﬁcant and based on only 10 men with occu­
pations categorized as outdoor. 
In unadjusted correlational analyses among the major 
factors of interest shown in Fig. 1, dairy intake was 
strongly correlated with calcium intake (Table 2); it was 
also weakly correlated with vitamin D intake, but this was 
signiﬁcant only when all men were included (Table 2). 
Vitamin D intake was correlated with 25(OH)D level, but 
only among men with low vitamin D status. Similarly, 
25(OH)D and 1,25(OH)2D levels were correlated only 
among men with low vitamin D status. 1,25(OH)2D was 
not correlated with intake of dairy foods, calcium, or 
vitamin D in these analyses. 
In multivariate linear regression analyses adjusting for 
BMI and alcohol intake as well as for age and race, we 
observed no associations of total dairy food, total milk, 
calcium, or vitamin D intake with 1,25(OH)2D levels in 
models including all men, nor we did we see any evidence 
of effect modiﬁcation by vitamin D status (Table 3). We 
also saw no associations when we examined whole milk 
and low fat milk separately (data not shown). When we 
created categories to distinguish men with very high cal­
cium intake, we still found no evidence that calcium 
[1,500 mg/day was associated with lower 1,25(OH)2D 
levels, although the estimate for the highest category was 
based on only 16 men (data not shown). 
In exploring our hypothesized associations among 
dairy food intake, vitamin D intake, and levels of 
25(OH)D and 1,25(OH)2D, we found that dietary vitamin 
D was signiﬁcantly (beta = 0.004, p = 0.0001) associated 
with 25(OH)D levels after adjustment for age, race, BMI, 
intake of energy, alcohol, and calcium, and season of 
Table 1 Distribution of variables among 296 participants in the Prostate Cancer Risk Assessment Program, and age- and race-adjusted 
associations with 1,25(OH)2D 
Variable Betaa (p-value) 
Mean (±SD) age (years) 49.9 (8.6) \0.1 (0.52) 
African American (%) 66 0.9 (0.64) 
Level of education (%) 
High school graduate 19 Ref 
Some college 36 3.8 (0.14) 
College graduate 27 2.5 (0.37) 
Graduate degree 18 1.8 (0.54) 
Mean (±SD) BMI (kg/m2)b 28.9 (5.1) -0.3 (0.08) 
Physical activity (h/week) 2.4 (2.1) -0.3 (0.61) 
Dairy food intake (times/week) 
Mean (SD) 10.5 (8.8) 0.1 (0.50) 
Median (1st, 3rd quartiles) 8.4 (3.9, 14.2) 
Total milk intake (times/week) 
Mean (SD) 3.2 (4.5) 0.2 (0.32) 
Median (1st, 3rd quartiles) 1.0 (0.5, 3.5) 
Whole milk intake (times/week) 
Mean (SD) 0.6 (1.5) 0.3 (0.64) 
Median (1st, 3rd quartiles) 0 (0, 0.5) 
Skim/low fat milk intake (times/week) 
Mean (SD) 2.6 (4.6) 0.2 (0.4) 
Median (1st, 3rd quartiles) 0.5 (0, 3.0) 
Mean (SD) energy intake (kcal/day) 1,982 (742) -1.3 (0.28) 
Mean (SD) calcium intake (mg/day) 718 (414) 1.1 (0.27) 
Mean (SD) vitamin D intake (IU/day) 374 (312) 0.6 (0.06) 
Alcohol intake (%) 
0 g/day 34 Ref 
[0 to  \6.5 g/day 27 3.5 (0.14) 
[6.5 to \26 g/day 29 4.1 (0.09) 
C26 g/day 10 6.6 (0.05) 
p-For-trendc 0.06 
Occupational sun exposure (%) 
Indoor 68 Ref 
Mixed 26 0.9 (0.78) 
Outdoor 6 -0.9 (0.87) 
Season of blood draw (%) 
January–March 28 Ref 
April–June 22 1.9 (0.47) 
July–September 25 0.2 (0.94) 
October–December 25 0.8 (0.76) 
Mean (±SD) 25(OH)D (ng/mL) 15.9 (6.8) 0.5 (0.0005) 
25(OH)D B 15 ng/mL (%) 47 -4.6 (0.02) 
Mean (±SD) 1,25(OH)2D (pg/mL) 37.2 (15.7) – 
a Beta represents mean change in 1,25(OH)2D (pg/mL) for each 1,000 kcal increment in energy intake, 350 mg increment in calcium intake, and 
100 IU increment in vitamin D intake. For all other continuous variables, beta represents mean change in outcome variable for each one-unit 
increment in predictor variable. For categorical variables, betas represent mean difference in outcome relative to referent category 
b Due to missing data, n = 288 for BMI; n = 192 for physical activity; and n = 164 for occupational sun exposure 
c Trend p-value calculated by including alcohol as an ordinal categorical variable in the model 
Table 2 Spearman correlations among dairy food (servings/week), calcium (mg/day), and vitamin D (IU/day) intake and levels of 25(OH)D (ng/ 
mL) and 1,25(OH)2D (pg/mL) among all 296 participants in the Prostate Cancer Risk Assessment Program, and stratiﬁed on vitamin D status 
Dairy food Calcium Vitamin D 25(OH)D 1,25(OH)2D 
All men (n = 296) 
Dairy food 1.0 0.53a 0.15 0.21 0.01 
(p < 0.0001) (p 5 0.008) (p 5 0.0003) (p = 0.87) 
Calcium 1.0 0.36 0.29 0.05 
(p < 0.0001) (p < 0.0001) (p = 0.39) 
Vitamin D 1.0 0.24 0.10 
(p < 0.0001) (p = 0.10) 
25(OH)D 1.0 0.17 
(p = 0.003) 
1,25(OH)2D 1.0 
25(OH)D [ 15 ng/mL (n = 157) 
Dairy food 1.0 0.56 0.14 0.003 -0.002 
(p < 0.0001) (p = 0.09) (p = 0.97) (p = 0.98) 
Calcium 1.0 0.31 0.11 0.05 
(p < 0.0001) (p = 0.19) (p = 0.52) 
Vitamin D 1.0 0.07 0.12 
(p = 0.39) (p = 0.13) 
25(OH)D 1.0 0.11 
(p = 0.17) 
1,25(OH)2D 1.0 
25(OH)D B 15 ng/mL (n = 139) 
Dairy food 1.0 0.44 0.11 0.09 -0.02 
(p < 0.0001) (p = 0.21) (p = 0.27) (p = 0.86) 
Calcium 1.0 0.37 0.24 -0.001 
(p < 0.0001) (p 5 0.004) (p = 0.99) 
Vitamin D 1.0 0.32 0.01 
(p 5 0.0002) (p = 0.89) 
25(OH)D 1.0 0.25 
(p 5 0.004) 
1,25(OH)2D 1.0 
Calcium and vitamin D intake were adjusted for energy intake using the residual method 
a Boldface indicates p \ 0.05 
blood draw, regardless of vitamin D status (results not 
shown). Levels of 25(OH)D, in turn, were signiﬁcantly 
associated with 1,25(OH)2D levels, but only among men 
with 25(OH)D levels B 15 ng/mL [beta = 0.98 (p = 
0.01) for men with 25(OH)D B 15 ng/mL vs. beta = 0.37 
(p = 0.28) for men with 25(OH)D [ 15 ng/mL]. Dairy 
intake, however, was only weakly correlated with estimated 
intake of vitamin D (Table 2), and neither dairy nor vitamin 
D intake was associated with 1,25(OH)2D level (Table 3). 
Discussion 
We found that dairy food and calcium intake were not 
associated with 1,25(OH)2D levels in our sample of men at 
high risk for prostate cancer. Results did not differ by 
vitamin D status or race, although an association of 
25(OH)D with 1,25(OH)2D levels was limited to men with 
25(OH)D levels B 15 ng/mL. 
A potentially suppressive effect of calcium on produc­
tion and circulating levels of 1,25(OH)2D is a primary 
mechanism that has been suggested to explain the fairly 
consistent association of dairy and calcium intake with 
elevated prostate cancer risk. Prostate cells express 
1a-hydroxylase, the enzyme that converts 25(OH)D to 
1,25(OH)2D, but prostate cancer cells show a marked 
decrease in 1a-hydroxylase activity [14], thus, possibly 
increasing prostatic cell dependence on circulating 1,25 
(OH)2D [15]. In experimental studies, 1,25(OH)2D reduces 
cell proliferation, induces cell differentiation and 
Table 3 Multivariate-adjusted mean 1,25(OH)2D levels by categories of dairy food, milk, calcium, and vitamin D intake in all men and stratiﬁed 
on vitamin D status 
Median All men 25(OH)D [ 15 ng/mL 25(OH)D B 15 ng/mL 
n = 288 n = 154 n = 134 
n Mean 1,25(OH)2D n Mean 1,25(OH)2D n Mean 1,25(OH)2D 
(pg/mL) (pg/mL) (pg/mL) 
Dairy (times/week) 
Quartile 1 3 74 36.7 29 41.4 45 33.7 
Quartile 2 7 70 36.8 35 38.4 35 35.0 
Quartile 3 10 70 37.1 37 34.8 33 40.5 
Quartile 4 20 74 39.0 53 41.7 21 33.9 
p-Valuea 0.45 0.40 0.95 
Total milk (times/week) 
Quartile 1 0 69 35.8 36 36.9 33 33.8 
Quartile 2 0.5 81 36.8 36 41.6 45 32.7 
Quartile 3 3 67 39.6 29 39.5 38 38.9 
Quartile 4 7 71 38.3 53 38.4 18 37.3 
p-Value 0.27 0.49 0.53 
Calcium (mg/day) 
Quartile 1 427 69 37.0 29 38.4 40 34.9 
Quartile 2 571 73 36.2 32 37.4 41 34.9 
Quartile 3 725 72 38.1 41 39.4 31 36.6 
Quartile 4 1,033 74 38.5 52 40.8 22 35.5 
p-Value 0.40 0.41 0.69 
Vitamin D (IU/day) 
Quartile 1 116 71 36.4 29 33.4 42 38.6 
Quartile 2 190 72 34.6 39 38.0 33 30.4 
Quartile 3 397 72 40.3 37 43.3 35 37.0 
Quartile 4 675 73 38.8 49 40.7 24 34.9 
p-Value 0.15 0.14 0.96 
Model adjusted for age, race, total energy intake, BMI, and alcohol intake. Models for calcium and vitamin D intake also adjusted for the others 
as a continuous variable 
a p-Value for continuous variable 
apoptosis, and disturbs cell survival signals in the signaling 
pathway [16, 17], and these effects have been conﬁrmed in 
prostate epithelial and cancer cells in animal models [3]. 
Despite tight regulation of circulating levels of 
1,25(OH)2D, calcium intake may affect 1,25(OH)2D levels 
by affecting circulating calcium levels. Low calcium levels 
stimulate the release of parathyroid hormone, which in turn 
stimulates the hydroxylation of 25(OH)D to 1,25(OH)2D. 
High calcium levels may have the opposite effect [3]. 
We hypothesized that by increasing calcium intake and 
availability, dairy food intake would be associated with 
lower 1,25(OH)2D levels; particularly, among men with 
adequate vitamin D status. Despite a strong correlation 
between dairy food and calcium intake (r = 0.50, 
p \ 0.0001), we did not observe an inverse association for 
dairy food or calcium intake with 1,25(OH)2D level, even 
in analyses limited to men with adequate vitamin D status, 
or in additional analyses examining very high calcium 
intake. While a recent analysis conducted in the Prostate, 
Lung, Colorectal, and Ovarian Cancer Screening Trials 
also showed no association between calcium intake and 
1,25(OH)2D levels [18], several other studies have shown 
an inverse correlation between the two [15, 19–26], even 
within the range of usual calcium intake [20–22]. Never­
theless, levels of 1,25(OH)2D are known to be tightly 
regulated [11], and most of the studies showed relatively 
small changes in 1,25(OH)2D levels with large variations 
in calcium intake. Together, these studies suggest that an 
association between calcium and 1,25(OH)2D, if any, is too 
modest to explain the association between calcium and 
prostate cancer risk. Moreover, despite fairly consistent 
ﬁndings of an association for dairy and calcium intake with 
prostate cancer, even studies on prediagnostic serum vita­
min D levels and prostate cancer are inconsistent [27–31]. 
Whether suppression of 1,25(OH)2D levels is the primary 
mechanism by which dairy/calcium increase prostate can­
cer risk, therefore, remains an open question. Examining 
determinants of intracellular rather than circulating 
1,25(OH)2D may yield more insight into prostate cancer 
risk, although measurement of intracellular 1,25(OH)2D in  
epidemiologic studies poses logistical challenges. 
Among men with low vitamin D status we hypothesized 
that by increasing vitamin D intake dairy food intake would 
increase rather than decrease 1,25(OH)2D levels. The null 
ﬁndings in this low vitamin D status sample—mean 
25(OH)D in our sample was 15.9 ng/mL, compared with 
31.5 ng/mL in the Third National Health and Nutrition 
Examination Survey (20.9 ng/mL among black participants 
only) [32]—argues against this hypothesis. Although vita­
min D intake in our sample was signiﬁcantly associated 
with higher 25(OH)D levels, which was in turn associated 
with higher 1,25(OH)2D levels, dairy food intake was only 
weakly correlated with vitamin D intake, suggesting that 
other dietary sources of vitamin D are likely to be impor­
tant. Also worth noting is that dietary vitamin D was not 
associated with 1,25(OH)2D level, possibly due in part to 
tight regulation of 1,25(OH)2D, as well as to measurement 
error in estimating vitamin D intake [11]. Notably, previ­
ous studies have also not demonstrated a protective effect 
of dietary vitamin D for prostate cancer [22, 33–36]. 
We observed a marginally signiﬁcant association of 
alcohol intake with 1,25(OH) 2D level. Alcohol abuse is 
known to disrupt bone metabolism, but the limited evi­
dence available suggests that it would decrease rather than 
increase 1,25(OH)2D level [37]. With no a priori reason to 
expect a positive association between alcohol intake and 
1,25(OH) 2D, this ﬁnding warrants conﬁrmation in other 
studies before further interpretation is possible. 
Several limitations of this analysis merit discussion. 
First, our sample included men at high genetic risk for 
prostate cancer based on their race and/or family history. To 
the extent that circulating levels of 1,25(OH)2D are genet­
ically inﬂuenced, their heritable component may over­
whelm the effects of non-genetic factors such as diet. While 
it is unlikely that high risk men would be less responsive to 
dietary factors inﬂuencing vitamin D levels, we did attempt 
to account for genetic effects using information on men’s 
family history of prostate cancer but saw no association of 
family history with 1,25(OH)2D levels. Also, because black 
participants were eligible for PRAP regardless of their 
family history of prostate cancer, our ﬁndings have impli­
cations for black men in general. Indeed, despite our rela­
tively small sample size, our analysis is the largest 
examination of these relationships among black men. 
Measurement error in estimating dietary intake is 
another potential limitation, although one study demon­
strated good validity of the questionnaire in an ethnically 
diverse sample [38]. That dietary questionnaires were not 
always completed at the same time as the blood collection 
may have led to some error as well, although the median 
time between dietary questionnaire completion and blood 
draw for the 296 men in our analysis was only 12 days. 
In summary, in this sample of men at high risk for 
prostate cancer, dairy, milk, and calcium intake were not 
associated with reduced 1,25(OH)2D levels. Among men 
with low vitamin D status, vitamin D intake contributed to 
higher 25(OH)D levels, which were in turn associated with 
levels of 1,25(OH)2D, but we were unable to conﬁrm a 
direct association of dairy or vitamin D intake with 
1,25(OH)2D levels in these men. Our ﬁndings, in a sample 
including a large proportion of black participants, do not 
conﬁrm previous ﬁndings showing an inverse association 
between calcium intake and 1,25(OH)2D levels. As such, 
they suggest that future work should explore other mech­
anisms by which dairy foods and calcium might increase 
prostate cancer risk. 
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